AudioScholar Infectious Disease Weekly

By AudioScholar

Infectious Disease — a weekly podcast briefing of the most significant peer-reviewed infectious disease literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about AudioScholar Infectious Disease Weekly:

How many episodes does AudioScholar Infectious Disease Weekly have?

The podcast currently has 14 episodes available.

AudioScholar Infectious Disease Weekly episodes:

June 06, 2026This Week in Infectious Disease — Jun 6, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning the global fight against antimicrobial resistance, new insights into host immunology and viral reservoirs, and key updates in prevention and therapeutics. We'll also note two important dispatches from the field on drug-resistant malaria and the Sudan Virus. Let's dive in.
We begin with antimicrobial re…
This week's papers:
Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation. — The Lancet. Global health 2026
Plasma signals of lung tumor promotion for molecular cancer prevention. — Cell 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. — JAMA 2026
A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome. — Nature 2026
Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy. — The New England journal of medicine 2026
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda. — The New England journal of medicine 2026
Sudan Virus Disease in Uganda, 2025. — The New England journal of medicine 2026
HIV-1 infection converts CD4T cells to HLA class II-restricted CD8T cells. — Science translational medicine 2026
Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance. — Emerging infectious diseases 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development. — The Lancet. Infectious diseases 2025
Listen at AudioScholar
...more
10min
May 28, 2026This Week in Infectious Disease — May 28, 2026
Welcome to This Week in Infectious Disease. This week we're covering 10 notable papers spanning diagnostics and stewardship, new therapies for major global infections, and key updates in public health and epidemiology. Let's dive in.
We begin this week with a focus on diagnostics and antimicrobial stewardship, a constant challenge in an era of rising resistance.
The Study
A major open-label ran…
This week's papers:
Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. — The New England journal of medicine 2026
Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trial. — The Lancet. Infectious diseases 2026
Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: A systematic review and meta-analysis. — PLoS medicine 2026
U = U for all: Advancing equity in HIV prevention. — PLoS medicine 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial. — JAMA 2026
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study. — The Lancet. Infectious diseases 2026
Varicella zoster virus and the central nervous system. — Nature reviews. Microbiology 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial. — The Lancet. Infectious diseases 2026
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia. — The Lancet. Infectious diseases 2025
Listen at AudioScholar
...more
12min
May 21, 2026This Week in Infectious Disease — May 21, 2026
Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning advances in HIV prevention and management, antimicrobial stewardship in common outpatient infections, and the global landscape of surveillance, new drugs, and prevention. Let's dive in.
Our first theme is advances in HIV prevention and management, with three papers from Clinical Infectious Diseases that…
This week's papers:
Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalence. — The Lancet. Infectious diseases 2026
Azithromycin for Preschoolers with Wheezing in the Emergency Department. — The New England journal of medicine 2026
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. — Lancet (London, England) 2026
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial. — Lancet (London, England) 2026
Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults. — JAMA 2026
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies. — Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026
Listen at AudioScholar
...more
13min
May 14, 2026This Week in Infectious Disease — May 14, 2026
Welcome to This Week in Infectious Disease. This week we're covering 8 notable papers spanning global health prevention, neonatal sepsis, and the evolving landscape of viral infections. Let's dive in.
Our first theme is rethinking prevention strategies in global health, with new data on tuberculosis, malaria, and schistosomiasis.
Two papers this week offer fresh perspectives on curbing tuberculo…
This week's papers:
Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission. — The Lancet. Infectious diseases 2026
Post-mortem characterisation of pathogen-specific causes of infection-related deaths in African and south Asian neonates: a prospective, observational, multicentre study. — The Lancet. Infectious diseases 2026
Sex-specific presentation, epidemiology, and control of schistosomiasis in women and adolescent girls. — The Lancet. Global health 2026
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts. — The New England journal of medicine 2026
Contribution of nosocomial transmission to Klebsiella pneumoniae neonatal sepsis in Africa and South Asia: An observational study of infection clusters inferred from pathogen genomics and temporal data. — PLoS medicine 2026
Global, regional, and national estimates of tuberculosis incidence averted by eliminating undernutrition in adults: a modelling study. — The Lancet. Global health 2026
Impact of introducing RTS,S/AS01malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme. — Lancet (London, England) 2026
Respiratory viral infections prime accelerated lung cancer growth. — Cell 2026
Listen at AudioScholar
...more
11min

FAQs about AudioScholar Infectious Disease Weekly:

How many episodes does AudioScholar Infectious Disease Weekly have?

The podcast currently has 14 episodes available.